Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 95

1.

Bone marrow-derived fibroblasts are a functionally distinct stromal cell population in breast cancer.

Raz Y, Cohen N, Shani O, Bell RE, Novitskiy SV, Abramovitz L, Levy C, Milyavsky M, Leider-Trejo L, Moses HL, Grisaru D, Erez N.

J Exp Med. 2018 Dec 3;215(12):3075-3093. doi: 10.1084/jem.20180818. Epub 2018 Nov 23.

PMID:
30470719
2.

Attenuated DNA damage responses and increased apoptosis characterize human hematopoietic stem cells exposed to irradiation.

Biechonski S, Olender L, Zipin-Roitman A, Yassin M, Aqaqe N, Marcu-Malina V, Rall-Scharpf M, Trottier M, Meyn MS, Wiesmüller L, Beider K, Raz Y, Grisaru D, Nagler A, Milyavsky M.

Sci Rep. 2018 Apr 17;8(1):6071. doi: 10.1038/s41598-018-24440-w.

3.

Is outpatient hysteroscopy accurate for the diagnosis of endometrial pathology among perimenopausal and postmenopausal women?

Bar-On S, Ben-David A, Rattan G, Grisaru D.

Menopause. 2018 Feb;25(2):160-164. doi: 10.1097/GME.0000000000000961.

PMID:
28763396
4.

[HORMONE REPLACEMENT THERAPY AFTER GYNECOLOGICAL MALIGNANCIES].

Michaan N, Grisaru D.

Harefuah. 2017 Mar;156(3):163-166. Review. Hebrew.

PMID:
28551932
5.

Quercetin alters the DNA damage response in human hematopoietic stem and progenitor cells via TopoII- and PI3K-dependent mechanisms synergizing in leukemogenic rearrangements.

Biechonski S, Gourevich D, Rall M, Aqaqe N, Yassin M, Zipin-Roitman A, Trakhtenbrot L, Olender L, Raz Y, Jaffa AJ, Grisaru D, Wiesmuller L, Elad D, Milyavsky M.

Int J Cancer. 2017 Feb 15;140(4):864-876. doi: 10.1002/ijc.30497. Epub 2016 Nov 22.

6.

What is the right timing for ultrasound evaluation after pregnancy termination with mifepristone?

Amer-Alshiek J, Shiekh O, Agmon A, Grisaru D.

Eur J Obstet Gynecol Reprod Biol. 2015 Jun;189:24-6. doi: 10.1016/j.ejogrb.2015.03.018. Epub 2015 Mar 28.

PMID:
25845913
7.

Uterine peristalsis-induced stresses within the uterine wall may sprout adenomyosis.

Shaked S, Jaffa AJ, Grisaru D, Elad D.

Biomech Model Mechanobiol. 2015 Jun;14(3):437-44. doi: 10.1007/s10237-014-0614-4. Epub 2014 Sep 13.

PMID:
25217062
8.

Cytoreduction surgery with hyperthermic intraperitoneal chemotherapy in recurrent ovarian cancer improves progression-free survival, especially in BRCA-positive patients- a case-control study.

Safra T, Grisaru D, Inbar M, Abu-Abeid S, Dayan D, Matceyevsky D, Weizman A, Klausner JM.

J Surg Oncol. 2014 Nov;110(6):661-5. doi: 10.1002/jso.23688. Epub 2014 Jun 24.

PMID:
24962381
9.

The role of C-reactive protein measurement as a diagnostic aid in early pregnancy.

Cohen Y, Ascher-Landsberg J, Cohen A, Lessing JB, Grisaru D.

Eur J Obstet Gynecol Reprod Biol. 2014 May;176:64-7. doi: 10.1016/j.ejogrb.2014.03.004. Epub 2014 Mar 12.

PMID:
24680394
10.

The combination of gemcitabine and carboplatin shows similar efficacy in the treatment of platinum-resistant and platinum-sensitive recurrent epithelial ovarian cancer patients.

Safra T, Asna N, Veizman A, Shpigel S, Matcejevsky D, Inbar M, Grisaru D.

Anticancer Drugs. 2014 Mar;25(3):340-5. doi: 10.1097/CAD.0000000000000042.

PMID:
24185383
11.

Endurance exercise diverts the balance between Th17 cells and regulatory T cells.

Perry C, Pick M, Bdolach N, Hazan-Halevi I, Kay S, Berr I, Reches A, Harishanu Y, Grisaru D.

PLoS One. 2013 Oct 9;8(10):e74722. doi: 10.1371/journal.pone.0074722. eCollection 2013.

12.

Weekly carboplatin with paclitaxel compared to standard three-weekly treatment in advanced epithelial ovarian carcinoma--a retrospective study.

Safra T, Shamai S, Greenberg J, Veizman A, Shpigel S, Matcejevsky D, Pelles S, Inbar M, Levy T, Grisaru D.

Gynecol Oncol. 2014 Jan;132(1):18-22. doi: 10.1016/j.ygyno.2013.06.013. Epub 2013 Jul 10.

PMID:
23850468
13.

Fluid-flow induced wall shear stress and epithelial ovarian cancer peritoneal spreading.

Avraham-Chakim L, Elad D, Zaretsky U, Kloog Y, Jaffa A, Grisaru D.

PLoS One. 2013 Apr 10;8(4):e60965. doi: 10.1371/journal.pone.0060965. Print 2013.

14.

Are the human papillomavirus genotypes different in cervical cancer and intraepithelial neoplasia in Jewish Israeli women, a low-risk population?

Laskov I, Grisaru D, Efrat G, Trejo LL, Grisaru G, Avidor B.

Int J Gynecol Cancer. 2013 May;23(4):730-4. doi: 10.1097/IGC.0b013e318288eee5.

PMID:
23446379
15.

Correlation of cancer risk evaluation and early detection (CADET) scores with abnormal ultrasonographic ovarian findings.

Hasson J, Rattan G, Heller I, Lessing JB, Grisaru D.

Eur J Gynaecol Oncol. 2012;33(3):265-8.

PMID:
22873096
16.

Estrogen-dependent variations in 18F-fluorodeoxyglucose uptake in uterine leiomyomas.

Lerman H, Bar-On S, Helpman L, Even-Sapir E, Grisaru D.

Int J Gynecol Cancer. 2012 Sep;22(7):1187-91. doi: 10.1097/IGC.0b013e31825bedc7.

PMID:
22801027
17.

A peculiar presentation: for 2 women, a rare infection preceded a more urgent diagnosis.

Grisaru D, Raz Y, Shtabsky A.

Am J Obstet Gynecol. 2012 Oct;207(4):342.e1-2. doi: 10.1016/j.ajog.2012.05.024. Epub 2012 Jun 1. No abstract available.

PMID:
22704763
18.

Increased CD39 expression on CD4(+) T lymphocytes has clinical and prognostic significance in chronic lymphocytic leukemia.

Perry C, Hazan-Halevy I, Kay S, Cipok M, Grisaru D, Deutsch V, Polliack A, Naparstek E, Herishanu Y.

Ann Hematol. 2012 Aug;91(8):1271-9. doi: 10.1007/s00277-012-1425-2. Epub 2012 Feb 16.

PMID:
22349724
19.

Reciprocal changes in regulatory T cells and Th17 helper cells induced by exercise in patients with chronic lymphocytic leukemia.

Perry C, Herishanu Y, Hazan-Halevy I, Kay S, Bdolach N, Naparstek E, Polliack A, Grisaru D.

Leuk Lymphoma. 2012 Sep;53(9):1807-10. doi: 10.3109/10428194.2012.656634. Epub 2012 Feb 13. No abstract available.

PMID:
22242820
20.

Early adenocarcinoma of the cervix: is radical vaginal trachelectomy safe?

Helpman L, Grisaru D, Covens A.

Gynecol Oncol. 2011 Oct;123(1):95-8. doi: 10.1016/j.ygyno.2011.06.024. Epub 2011 Jul 20.

PMID:
21774971
21.

Mimicking the haematopoietic niche microenvironment provides a novel strategy for expansion of haematopoietic and megakaryocyte-progenitor cells from cord blood.

Deutsch V, Hubel E, Kay S, Ohayon T, Katz BZ, Many A, Zander A, Naparstek E, Grisaru D.

Br J Haematol. 2010 Apr;149(1):137-49. doi: 10.1111/j.1365-2141.2009.08041.x. Epub 2010 Jan 18.

PMID:
20085580
22.

Comparison of adnexal torsion between pregnant and nonpregnant women.

Hasson J, Tsafrir Z, Azem F, Bar-On S, Almog B, Mashiach R, Seidman D, Lessing JB, Grisaru D.

Am J Obstet Gynecol. 2010 Jun;202(6):536.e1-6. doi: 10.1016/j.ajog.2009.11.028. Epub 2010 Jan 8.

PMID:
20060090
23.

CYP1A1 and CYP2D6 gene polymorphisms in Israeli Jewish women with cervical cancer.

Gutman G, Morad T, Peleg B, Peretz C, Bar-Am A, Safra T, Grisaru D.

Int J Gynecol Cancer. 2009 Nov;19(8):1300-2. doi: 10.1111/IGC.0b013e3181b9fa5d.

PMID:
20009880
24.

Systematic antigenic profiling of hematopoietic antigens on ovarian carcinoma cells identifies membrane proteins for targeted therapy development.

Helpman L, Katz BZ, Safra T, Schreiber L, Levine Z, Nemzer S, Kinar Y, Grisaru D.

Am J Obstet Gynecol. 2009 Aug;201(2):196.e1-7. doi: 10.1016/j.ajog.2009.05.013.

PMID:
19646570
25.

A feasibility study of weekly docetaxel with capecitabine in ovarian cancer: a promising combination of two active drugs with a potential for synergism.

Safra T, Bernstein Molho R, Menzcher J, Inbar M, Grisaru D, Levy T.

Chemotherapy. 2009;55(4):298-302. doi: 10.1159/000224658. Epub 2009 Jun 10.

PMID:
19521076
26.

Combined weekly carboplatin and paclitaxel as primary treatment of advanced epithelial ovarian carcinoma.

Safra T, Menczer J, Bernstein RM, Shpigel S, Matcejevsky D, Inbar MJ, Golan A, Grisaru D, Levy T.

Gynecol Oncol. 2009 Aug;114(2):215-8. doi: 10.1016/j.ygyno.2009.04.008. Epub 2009 May 14.

PMID:
19446318
27.

Mass effect: four months after a failed pregnancy, the patient was fatally ill.

Grisaru D, Reches A, Nimrod A.

Am J Obstet Gynecol. 2009 Feb;200(2):214.e1-2. doi: 10.1016/j.ajog.2008.08.057. Epub 2008 Nov 18. No abstract available.

PMID:
19019326
28.

Characteristics of microorganisms cultured from infected wounds post-hysterectomy.

Yerushalmy A, Reches A, Lessing JB, Schechner V, Carmeli Y, Grisaru D.

Eur J Obstet Gynecol Reprod Biol. 2008 Dec;141(2):169-72. doi: 10.1016/j.ejogrb.2008.07.024. Epub 2008 Sep 4.

PMID:
18775598
29.

Alternate AChE-R variants facilitate cellular metabolic activity and resistance to genotoxic stress through enolase and RACK1 interactions.

Mor I, Bruck T, Greenberg D, Berson A, Schreiber L, Grisaru D, Soreq H.

Chem Biol Interact. 2008 Sep 25;175(1-3):11-21. doi: 10.1016/j.cbi.2008.05.019. Epub 2008 May 18.

PMID:
18572152
30.

Pilot study of prevalence of high-risk human papillomavirus genotypes in Israeli Jewish women referred for colposcopic examination.

Grisaru D, Avidor B, Niv J, Marmor S, Almog B, Leibowitz C, Graidy M, Giladi M.

J Clin Microbiol. 2008 May;46(5):1602-5. doi: 10.1128/JCM.02483-07. Epub 2008 Mar 5.

31.

Improved quality of life with hyperbaric oxygen therapy in patients with persistent pelvic radiation-induced toxicity.

Safra T, Gutman G, Fishlev G, Soyfer V, Gall N, Lessing JB, Almog R, Matcievsky D, Grisaru D.

Clin Oncol (R Coll Radiol). 2008 May;20(4):284-7. doi: 10.1016/j.clon.2007.12.005. Epub 2008 Jan 28.

PMID:
18222656
32.

Heparanase expression increases throughout the endometrial hyperplasia-cancer sequence.

Canaani J, Ilan N, Back S, Gutman G, Vlodavsky I, Grisaru D.

Int J Gynaecol Obstet. 2008 May;101(2):166-71. doi: 10.1016/j.ijgo.2007.10.019. Epub 2008 Jan 24.

PMID:
18221741
33.

Acetylcholinesterase-R increases germ cell apoptosis but enhances sperm motility.

Mor I, Sklan EH, Podoly E, Pick M, Kirschner M, Yogev L, Bar-Sheshet Itach S, Schreiber L, Geyer B, Mor T, Grisaru D, Soreq H.

J Cell Mol Med. 2008 Apr;12(2):479-95. doi: 10.1111/j.1582-4934.2008.00231.x. Epub 2008 Jan 11.

34.

Post-hysterectomy pelvic fluid collection: is it associated with febrile morbidity?

Hasson J, Maslovich S, Har-Toov J, Lessing JB, Grisaru D.

BJOG. 2007 Dec;114(12):1566-8.

35.

Microarray expression identification of differentially expressed genes in serous epithelial ovarian cancer compared with bulk normal ovarian tissue and ovarian surface scrapings.

Grisaru D, Hauspy J, Prasad M, Albert M, Murphy KJ, Covens A, Macgregor PF, Rosen B.

Oncol Rep. 2007 Dec;18(6):1347-56.

PMID:
17982616
36.

Sustained leukocyte count during rising cortisol level.

Deutsch V, Lerner-Geva L, Reches A, Boyko V, Limor R, Grisaru D.

Acta Haematol. 2007;118(2):73-6.

PMID:
17538247
37.

The effect of the readthrough acetylcholinesterase variant (AChE-R) on uterine muscle and leiomyomas.

Grisaru D, Keidar R, Schreiber L, Lessing JB, Deutsch V.

Mol Hum Reprod. 2007 May;13(5):351-4. Epub 2007 Mar 9.

PMID:
17350961
38.

Efficacy and toxicity of weekly topotecan in recurrent epithelial ovarian and primary peritoneal cancer.

Safra T, Menczer J, Bernstein R, Shpigel S, Inbar MJ, Grisaru D, Golan A, Levy T.

Gynecol Oncol. 2007 Apr;105(1):205-10. Epub 2007 Jan 18.

PMID:
17239430
39.

Survivin expression in the ureteral wall of high degree vesicoureteral reflux in children.

Joseph B, Letizia S, Grisaru D, Bar-Yosef Y, Matzkin H, Ben-Chaim J.

Int Urol Nephrol. 2007;39(1):79-83. Epub 2007 Jan 4.

PMID:
17203351
40.

Prediction of cervical involvement in endometrial cancer by hysteroscopy.

Almog B, Gutman G, Lessing JB, Grisaru D.

Arch Gynecol Obstet. 2007 Jan;275(1):45-8. Epub 2006 Aug 12.

PMID:
16906402
41.

Integrated 18F-fluorodeoxyglucose positron emission tomography and computerized tomography in endodermal sinus tumor.

Klieger C, Dvir R, Even-Sapir E, Lessing JB, Burstein Y, Grisaru D.

Int J Gynecol Cancer. 2006 Jul-Aug;16(4):1685-8.

PMID:
16884385
42.

The pattern of Protease Activated Receptor 1 (PAR1) expression in endometrial carcinoma.

Granovsky-Grisaru S, Zaidoun S, Grisaru D, Yekel Y, Prus D, Beller U, Bar-Shavit R.

Gynecol Oncol. 2006 Dec;103(3):802-6. Epub 2006 Jul 27.

PMID:
16875721
43.

Heavily pretreated ovarian cancer patients treated by single-agent gemcitabine. A retrospective outcome comparison between platinum-sensitive and platinum-resistant patients.

Safra T, Ron I, Boaz M, Brenner J, Grisaru D, Inbar M, Hayat H, Menczer J, Golan A, Levy T.

Acta Oncol. 2006;45(4):463-8.

PMID:
16760183
44.

Hydrolytic and nonenzymatic functions of acetylcholinesterase comodulate hemopoietic stress responses.

Grisaru D, Pick M, Perry C, Sklan EH, Almog R, Goldberg I, Naparstek E, Lessing JB, Soreq H, Deutsch V.

J Immunol. 2006 Jan 1;176(1):27-35.

45.

Phase II study of weekly topotecan in patients with recurrent or persistent epithelial ovarian cancer.

Levy T, Inbar M, Menczer J, Grisaru D, Glezerman M, Safra T.

Gynecol Oncol. 2004 Dec;95(3):686-90.

PMID:
15581982
46.

Trophoblastic tissue spread to the sigmoid colon after uterine perforation.

Levin I, Grisaru D, Pauzner D, Almog B.

Obstet Gynecol. 2004 Nov;104(5 Pt 2):1172-4. Review.

PMID:
15516441
47.

Blood-cell-specific acetylcholinesterase splice variations under changing stimuli.

Pick M, Flores-Flores C, Grisaru D, Shochat S, Deutsch V, Soreq H.

Int J Dev Neurosci. 2004 Nov;22(7):523-31.

PMID:
15465282
48.

The diagnostic accuracy of 18F-fluorodeoxyglucose PET/CT in patients with gynecological malignancies.

Grisaru D, Almog B, Levine C, Metser U, Fishman A, Lerman H, Lessing JB, Even-Sapir E.

Gynecol Oncol. 2004 Sep;94(3):680-4.

PMID:
15350358
49.

Combinatorial complexity of 5' alternative acetylcholinesterase transcripts and protein products.

Meshorer E, Toiber D, Zurel D, Sahly I, Dori A, Cagnano E, Schreiber L, Grisaru D, Tronche F, Soreq H.

J Biol Chem. 2004 Jul 9;279(28):29740-51. Epub 2004 Apr 28.

50.

Normal and abnormal 18F-FDG endometrial and ovarian uptake in pre- and postmenopausal patients: assessment by PET/CT.

Lerman H, Metser U, Grisaru D, Fishman A, Lievshitz G, Even-Sapir E.

J Nucl Med. 2004 Feb;45(2):266-71.

Supplemental Content

Loading ...
Support Center